Although Zhuang et al. identified LIPH as a novel unfavorable prognostic biomarker correlated with immunosuppression in pancreatic cancer patients with RNA-seq database, the relationship between LIPH with PAAD metastasis remains unclear (Zhuang et al., 2022). Here, LIPH is linked to familial pancreatic carcinoma.